Johnson Johnson Stock Today
| JNJ Stock | USD 160.64 1.00 0.63% |
Performance10 of 100
| Odds Of DistressLess than 3
|
Johnson Johnson is selling for 160.64 as of the 27th of July 2024. This is a 0.63% increase since the beginning of the trading day. The stock's last reported lowest price was 159.47. Johnson Johnson has a very small chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Note, on July 15, 2024, Representative Kevin Hern of US Congress acquired under $15k worth of Johnson Johnson's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 24th of September 1944 | Category Healthcare | Classification Health Care |
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 2.41 B outstanding shares of which 17.99 M shares are currently shorted by investors with about 2.71 days to cover. More on Johnson Johnson
Moving together with Johnson Stock
| 0.69 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
Moving against Johnson Stock
Follow Valuation Options Odds of Bankruptcy
Fiscal Year End 28th of January 2025
Johnson Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman | Alex Gorsky | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | Showing 3 out of 5 themes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Johnson & Johnson | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Dow Jones Industrial, NYSE Composite, SP 500 Index, Nasdaq CTA Artificial, SP 100 Index, SP 100, NYSE 100 Index, Dow Jones Composite, ARCA Pharmaceutical, ARCA Institutional, ARCA Major Markets, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, Investor Favorites, Corona Opportunity, Compulsion, Baby Boomer Prospects, Dividend Beast, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsJohnson Johnson can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Johnson Johnson's financial leverage. It provides some insight into what part of Johnson Johnson's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Johnson Johnson (JNJ) is traded on New York Stock Exchange in USA. It is located in One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 and employs 131,900 people. Johnson Johnson is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 384.2 B. Johnson Johnson runs under Pharmaceuticals sector within Health Care industry. The entity has 2.41 B outstanding shares of which 17.99 M shares are currently shorted by investors with about 2.71 days to cover.
Johnson Johnson has about 5.37 B in cash with 22.79 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.03.
Check Johnson Johnson Probability Of Bankruptcy
Ownership AllocationThe majority of Johnson Johnson outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Johnson Johnson to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Johnson Johnson. Please pay attention to any change in the institutional holdings of Johnson Johnson as this could imply that something significant has changed or is about to change at the company. Please note that on July 15, 2024, Representative Kevin Hern of US Congress acquired under $15k worth of Johnson Johnson's common stock.
Check Johnson Ownership Details
Johnson Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Legal & General Group Plc | 2024-03-31 | 23.3 M | |
| Bank Of New York Mellon Corp | 2024-03-31 | 22.1 M | |
| T. Rowe Price Associates, Inc. | 2024-03-31 | 21.8 M | |
| Wells Fargo & Co | 2024-03-31 | 18.6 M | |
| Capital Research & Mgmt Co - Division 3 | 2024-03-31 | 17.2 M | |
| Massachusetts Financial Services Company | 2024-03-31 | 16.9 M | |
| Fmr Inc | 2024-03-31 | 16.9 M | |
| Charles Schwab Investment Management Inc | 2024-03-31 | 16.2 M | |
| Amvescap Plc. | 2024-03-31 | 14.3 M | |
| Vanguard Group Inc | 2024-03-31 | 228.9 M | |
| Blackrock Inc | 2024-03-31 | 189.7 M |
Johnson Johnson Historical Income Statement
Johnson Stock Against Markets
Johnson Johnson Corporate Directors
| Jennifer Doudna | Independent Director | Profile | |
| Marillyn Hewson | Independent Director | Profile | |
| Mary Beckerle | Independent Director | Profile | |
| Darius Adamczyk | Independent Director | Profile |
Additional Information and Resources on Investing in Johnson Stock
When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.106 | Dividend Share 4.81 | Earnings Share 6.61 | Revenue Per Share 35.593 | Quarterly Revenue Growth 0.023 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.